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ABSTRACT
Rheumatoid arthritis, a systemic inflammatory disease, may induce pulmonary manifestations. We describe a case of longstanding RA 
presenting with eosinophilic pneumonia. Rare case reports of tissue eosinophilia involving isolated organs in the setting of rheumatoid 
arthritis exist in the literature. It has been shown that the production of proinflammatory cytokines activates different cell group and can 
simultaneously play a role in rheumatoid arthritis, and induce eosinophils infiltration in target tissue. An appropriate lowest possible dosage 
of steroid therapy is essential, whereas eosinophilic pneumonia may be a rare subset of pulmonary involvement in rheumatoid arthritis. 
LEARNING POINTS
• The lungs and pleura are frequently involved in rheumatoid arthritis and contribute between 10% and 20% of overall mortality.
• A patient with rheumatoid arthritis presenting with respiratory symptoms, serum eosinophilia and specific pulmonary radiological 
involvement, can in rare cases have eosinophilic pneumonia.
• There may be an association between hypereosinophilia and immunological alteration in rheumatoid arthritis.
• In this patient, treatment with prednisone and hydroxychloroquine achieved clinical remission.
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INTRODUCTION
Rheumatoid arthritis (RA) is a systemic inflammatory disease that primarily affects the synovial joints with a chronic progressive erosive 
synovitis which leads to destruction of both bone and cartilage. Multiple other organs may be involved, with extra-articular manifestations 
in the cardiovascular system, lungs, skin and eyes. The lungs and pleura are frequently involved and contribute between 10% and 20% of 
overall mortality. Recent pathogenetic findings provide fascinating insights into how pneumopathies may be related to the development of 
RA[1,2]. Pulmonary parenchymal lesions found in RA are classified into different histopathological subtypes. Eosinophilic pneumonia (EP) in 
RA is a clinical entity so uncommon it is rarely seen. Some authors[3,4] documented a hypereosinophilia in the serum of up to 40% of patients 
with RA during the active phase of the disease. Other authors[5-8] support the hypothesis that pathological activation of eosinophils may 
correlate with the presence of rheumatoid factor (RF) since a higher incidence of eosinophilic tissue infiltration was found in patients with 
eosinophilia and high serum RF.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2015_000241 European Journal of Case Reports in Internal Medicine © EFIM 2015
CASE REPORT
A 61-year-old Italian man, who used to smoke until he was 30 and with no known allergies, was admitted to our rheumatology department 
in 1990 for rapid progressive onset of symmetric arthritis, with swelling and tenderness on both the metacarpophalangeal and proximal 
interphalangeal joints of his hands and on the bilateral metatarsophalangeal joints of his feet. He also presented with considerable morning 
stiffness, significantly increased inflammatory markers and RF positivity. X-rays showed no signs of bone erosion. The patient was diagnosed 
with early-stage rheumatoid arthritis (RA) according to the 1987 American College of Rheumatology (ACR) criteria (the diagnosis would also 
be supported by the latest 2010 ACR criteria). Treatment with hydroxychloroquine (HCQ) 200 mg/day plus prednisone 5 mg/day produced 
an excellent clinical response. In February 2010, the patient had an episode of acute idiopathic (not lithiasic or alcoholic) pancreatitis. 
During hospitalization, radiological abdominal investigations were negative and the only pathological finding was constant leucocytosis 
with hypereosinophilia in blood tests, with average values of 22.3% of eosinophils (normal maximum 4%), with a mean absolute value of 
2.13/103/μl. Therapy consisted of 2 weeks of steroid treatment.
Continuing light therapy with HCQ prevented clinical, serological or radiological exacerbation or progression of the RA, with RF constantly 
positive with a medium titre of 44 IU/ml (normal value 20 IU/ml) and negative anti-citrullinated peptide antibodies (ACPA). Prednisone was 
suspended in April 2011. However, 4 months later, the patient was admitted to hospital with cough and high fever. Blood tests showed that 
eosinophils were consistently high with an average value of 21.2% (absolute value of 2.40/109/l). Chest x-rays showed extensive pulmonary 
parenchymal bilateral consolidations, mainly in the right upper lobe (Fig. 1). Computed tomography (CT) of the chest confirmed the presence 
of extensive bilateral nodular parenchymal infiltrates (Fig. 2). Bronchoscopy, cytology of bronchoalveolar fluid, cultures and virological tests 
were negative for tumours and infections, but the bronchoalveolar fluid demonstrated a high eosinophilic count (35%). Neither existing 
nor previous nasal polyposis or peripheral neuropathy were found. RF was 378 mg/dl, while anti-nuclear antibodies, extractable nuclear 
antigens, anti-dsDNA, anti-neutrophil cytoplasmic antibodies and ACPA antibodies were negative. Pulmonary function tests were normal..
Figure 1: Chest X-rays of the patient 
in 2011, at the time of diagnosis of 
Eosinophilic Pneumonia, showing 
pulmonary parenchymal bilateral 
consolidations, mainly at the right 
upper lobe.
Figure 2: Computes Tomography 
of the chest, dating in 2011, 
documenting the presence of 
bilateral parenchymal infiltrates of 
the lungs.
Transbronchial lung biopsy crucially demonstrated “fragments of bronchial wall with fibrosis and intense infiltrate of eosinophils and 
frustules of lung parenchyma with lympho-granulocyte inflammation with a rich eosinophilic interstitial component”. The diagnosis of 
eosinophilic pneumonia (EP) was followed by therapy consisting of high doses of steroids with rapid regression of clinical and radiological 
signs.
In October 2012, after a gradual tapering of steroids, a recurrence of the same pulmonary pattern of EP required that therapy be restarted. 
The reduction in prednisone to under 10 mg/day had caused the reappearance on CT of bilateral nodular consolidations, mainly in the upper 
lobes.
Currently, the patient is asymptomatic and continues steroid treatment with prednisone (10 mg/day) and HCQ. Laboratory and clinical 
values are satisfactory, with constant RF positivity (372 IU/ml in November 2013) and ACPA negativity. Structural deformation of the hands 
is shown in Figs. 3, 4 and 5. Chest x-rays and high-resolution CT are currently negative.
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DISCUSSION
In the setting of a hypereosinophilic state in RA (excluding allergic, infectious and drug-related disease), case reports of tissue eosinophilia 
involving isolated organs are rare in the literature, but the possibility of such an association between these haematological and 
rheumatological entities has been discussed[9-11].
The first description of EP associated with RA was provided by Payne et al.[12], who sought to demonstrate a common origin unrelated 
to autoimmunity. Later in 1985 Yousem et al.[3] histologically analysed the lungs of 40 randomly chosen patients with RA and associated 
pulmonary involvement: one of the 40 had an EP. Review of the literature does not reveal a correlation between the severity of EP and the 
time of diagnosis of RA, the patient’s age, sex or ACPA positivity.
In 2001 Van Esch et al.[13] described how (hyper)activation of T cells, through cross-linking with B cells mediated by CD40, is responsible 
simultaneously for systemic eosinophil chemotaxis and the production of RF.
More recently, the role of some interleukins (IL6, IL5, IL10) and chemokines (eotaxines 1 and 2) has been shown to induce eosinophil 
recruitment by macrophages and T lymphocytes and inhibit apoptosis of eosinophilic infiltrates in tissue.
As evidenced in animal studies[14], the mechanisms inducing eosinophilic recruitment are mainly driven by a lymphocyte-TH2 pathway. 
However, RA is a predominantly TH1/TH17-driven disease, while TH2-cytokines can have an ameliorating effect. 
Sandhya et al.[15] suggest that the switch from a TH1/TH17 to a TH2 immunological pathway may be the mechanism which both causes RA 
remission and induces the release of eosinophils into the blood stream, with consequent infiltration in specific target organs[16-18]. As shown 
by the data, our patient as well as those reported by other authors, had inactive RA at the time of diagnosis of eosinophilia[19].
CONCLUSION
The clinical picture of a patient with longstanding inactive deforming RA and presenting with respiratory symptoms, serum eosinophilia 
and specific pulmonary radiological involvement, could lead to a diagnosis of EP in rare cases. During the diagnostic pathway, drug-induced 
reactions, other interstitial pulmonary diseases as well as parasitic and viral infections have to be excluded as a first step.
Figure 3: Morphological deformations of hands 
that currently presents the patient.
Figure 4: X-ray image of the hands 
(posteroanterior view) showing articular 
deformation presented by the patient 
nowadays.
Figure 5: X-ray image of the hands (oblique 
view) showing articular deformation 
presented by the patient nowadays.
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Appropriate steroid treatment is essential. Our patient was maintained in clinical and radiological remission with prednisone 10 mg/day and 
HCQ 200 mg/day. Any reduction in steroid dosage, and of course its suspension, caused clinical, immunological and radiological reactivation. 
